AKT1 and PTEN hamartoma tumor syndrome: Germline heterozygous mutations in PTEN, a tumor suppressor gene that antagonizes the (PI3K)/AKT signaling, are linked to a wide range of MEG phenotypes, collectively referred as PTEN hamartoma tumor syndrome (PHTS).